You can do better than sleeping pills or counting sheep. From free apps and wearable trackers to smart mattresses and climate ...

By instilling these healthy habits in children, you can help them develop a strong foundation for a lifetime of wellness and ...

Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...

According to statistics by the American Association of Medicine, the disorder sleep apnea affects approximately 30 million US ...

Taking a GLP-1 may help treat sleep apnea since obesity is one of many factors that increases your likelihood of the sleep ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

How Genetic Factors Are Associated with Behavioral Side Effects of GLP-1 Weight Loss Medication Glucagon-like peptide 1 ...

LEXX READ THE FULL LEXX RESEARCH REPORT Lexaria Bioscience Corporation (NASDAQ:LEXX) reported fiscal first quarter 2025 results along with program updates, progress in its GLP-1 trials, a capital ...